Created with Sketch.

Larger cloth. Continued efficacy.

Medline | CHG

A new choice for pre-op skin antiseptic solutions.

Despite advances in surgical asepsis, surgical site infection (SSI) remains a challenging and costly problem. Annually, there are up to 300,000 SSIs at a cost between $3.5 and $10 billion.1

Optimal pre-operative patient skin prep “reduces contamination at the incisional site and may reduce the risk of SSIs.”2,3

With our new ReadyPrep CHG, a large pre-saturated 2% CHG cloth, you’re now ready to reduce the risk of SSIs by decolonizing the skin in a simple and standardized way.

Request samples
Group 31 Created with Sketch.

Step Up Your Prep™ to reduce the risk of SSIs

Larger cloth, continued efficacy help you step up your prep.

ReadyPrep CHG cloths can help you overcome the challenges of pre-operative skin prep to deliver an antiseptic agent consistently, safely and effectively. Here’s how:

Created with Sketch.

Large cloth
68% bigger than the market leader.4

Created with Sketch.

Consistent application
Each cloth contains 500 mg of CHG to help reduce bacteria that can cause SSIs.

Created with Sketch.

Continued efficacy
Reduces microorganisms on the skin for up to 6 hours after application.5

Created with Sketch.

Killing efficacy
Rapid kill time against a broad spectrum of microorganisms. Kills Staph aureus and other SSI-causing bacteria.6

Created with Sketch.

Long shelf life
Two-year shelf life6 can help reduce waste and save more money.

ReadyPrep CHG can help you protect your patients with each and every cloth.

ReadyPrep CHG is manufactured in a state-of-the-art facility equipped with the latest quality control systems that meet the standards of the pharmaceutical industry and are FDA compliant. Distinctive features and cost-saving benefits make ReadyPrep CHG the new choice for pre-op skin antiseptic solutions.

Effective CHG release

Single fiber technology in the 100% polyester cloth effectively and consistently releases CHG on skin.

Moisture-retaining packaging

Cutting-edge film barrier with a low moisture vapor transition rate (MVTR) helps keep our cloths moist and viable for long periods of time.

Long shelf life

Two-year shelf life6 can help you reduce waste and save more money.

FDA-approved ReadyPrep CHG formula exhibits broad-spectrum antimicrobial activity against common SSI-causing microorganisms6

The following microorganisms have also proven to show no evidence of resistance to the ReadyPrep CHG solution.

  • Acinetobacter baumannii
  • Burkholderia cepacia
  • Enterococcus faecalis
  • Escherichia coli
  • Pseudomonas aeruginosa
  • Serratia marcescens
  • Staphylococcus aureus7
  • Staphylococcus epidermidis

Request a sample and schedule a trial.

(For professional use only. Not for home use.)

Upon receipt, a Medline Representative will schedule a visit to present ReadyPrep CHG.

References:

  1. Surgical site infections are the most common and costly of hospital infections, Loyola University Health System. Available from Science Daily website https://www.sciencedaily.com/releases/2017/01/170119161551.htm. Accessed August 3, 2018.
  2. “Recommended practices for skin preparation of patients,” in Standards, Recommended Practices, and Guidelines (Denver: AORN, Inc, 2005) 443-446. Available from Outpatient Surgery Magazine. http://www.outpatientsurgery.net/guides/infection-control/2007/understanding-the-science-behind-prepping. Accessed August 3, 2018.
  3. Dohmen PM. “Influence of skin flora and preventive measures on surgical site infection during cardiac surgery.” Surg Infect (Larchmt). 2006;7 Suppl 1:S13-7.Available from Outpatient Surgery Magazine. Accessed August 3, 2018. http://www.outpatientsurgery.net/guides/infection-control/2007/understanding-the-science-behind-prepping. Accessed August 3, 2018
  4. Compared to market leader.
  5. In vivo testing on file.
  6. In vitro testing on file.
  7. Staphylococcus aureus has been consistently shown as the leading cause of SSIs. Tong, Y.C., Steven, Davis, S. Joshua, et al. Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management, Clinical Microbiology Reviews, May 27, 2015. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4451395/. Accessed November 19, 2018.

How can we help you?

Contact Us
Call Us Now